ClinicalTrials.Veeva

Menu
D

Denver Health | Rocky Mountain Poison & Drug Safety

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Eslicarbazepine Acetate
Reparixin
Bupivacaine
Soliris
Vitamin C
phenylephrine
Pegcetacoplan
Brimonidine Tartrate
Ticagrelor
Steroids

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 42 total trials

Add-on Reparixin in Adult Patients With ARDS

Study objectives1. To characterize the efficacy of reparixin in ameliorating lung injury and systemic inflammation and expediting clinical recovery a...

Enrolling
Acute Respiratory Distress Syndrome, Adult
Drug: Reparixin 600mg
Other: Matching Placebo

Primary objective:- To evaluate the efficacy of oral reparixin versus standard care alone in limiting disease progression in adult patients hospitali...

Enrolling
Infectious Pneumonia
Severe COVID-19
Other: Placebo
Drug: Reparixin

Trial sponsors

D
University of Colorado Denver (CU Denver) logo
Kaiser Permanente logo
Dompé logo
A
A
B
C
Covidien logo
Emory University logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems